Directive 2006/126/EC of the European Parliament and of the CouncilShow full title

[F1 9.1. For the following cardiovascular conditions, driving licences may be issued or renewed for applicants or drivers in the indicated groups, only after the condition has been effectively treated and subject to competent medical authorisation and if appropriate, regular medical assessment: U.K.

(a)

brady-arrhythmias (sinus node disease and conduction disturbances) and tachy-arrhythmias (supraventricular and ventricular arrhythmias) with history of syncope or syncopal episodes due to arrhythmic conditions (applies to group 1 and 2);

(b)

brady-arrhythmias: sinus node disease and conduction disturbances with second degree atrioventricular (AV) block Mobitz II, third degree AV block or alternating bundle branch block (applies to group 2 only);

(c)

tachy-arrhythmias (supraventricular and ventricular arrhythmias) with

• structural heart disease and sustained ventricular tachycardia (VT) (applies to group 1 and 2), or

• polymorphic nonsustained VT, sustained ventricular tachycardia or with an indication for a defibrillator (applies to group 2 only);

(d)

symptomatic of angina (applies to group 1 and 2);

(e)

permanent pacemaker implantation or replacement (applies to group 2 only);

(f)

defibrillator implantation or replacement or appropriate or inappropriate defibrillator shock (applies to group 1 only);

(g)

syncope (a transient loss of consciousness and postural tone, characterised by rapid onset, short duration, and spontaneous recovery, due to global cerebral hypoperfusion, of presumed reflex origin, of unknown cause, with no evidence of underlying heart disease)(applies to group 1 and 2);

(h)

acute coronary syndrome (applies to group 1 and 2);

(i)

stable angina if symptoms do not occur with mild exercise (applies to group 1 and 2);

(j)

percutaneous coronary intervention (PCI) (applies to group 1 and 2);

(k)

coronary artery bypass graft surgery (CABG) (applies to group 1 and 2);

(l)

stroke/transient ischemic attack (TIA) (applies to group 1 and 2);

(m)

significant carotid artery stenosis (applies to group 2 only);

(n)

maximum aortic diameter exceeding 5,5 cm (applies to group 2 only);

(o)

heart failure:

• New York Heart Association (NYHA) I, II, III (applies to group 1 only),

• NYHA I and II provided that the left ventricular ejection fraction is at least 35 % (applies to group 2 only);

(p)

heart transplantation (applies to group 1 and 2);

(q)

cardiac assist device (applies to group 1 only);

(r)

valvular heart surgery (applies to group 1 and 2);

(s)

malignant hypertension (elevation in systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg associated with impending or progressive organ damage) (applies to group 1 and 2);

(t)

grade III blood pressure (diastolic blood pressure ≥ 110 mmHg and/or systolic blood pressure ≥ 180 mmHg) (applies to group 2 only);

(u)

congenital heart disease (applies to group 1 and 2);

(v)

hypertrophic cardiomyopathy if without syncope (applies to group 1 only);

(w)

long QT syndrome with syncope, Torsade des Pointes or QTc > 500 ms (applies to group 1 only).]

Textual Amendments

F1 Substituted by Commission Directive (EU) 2016/1106 of 7 July 2016 amending Directive 2006/126/EC of the European Parliament and of the Council on driving licences (Text with EEA relevance).